CNTX Context Therapeutics Inc.
Healthcare$2.60+8.33%ClosedMarket Cap: $238.9M
As of 2026-05-25
Analyst Consensus
Consensus
Buy
Target (Consensus)
$5.25
Target (Median)
$5.25
Target Range
$4.50 - $6.00
Upside from current price: 101.9%
Rating Distribution
3 Strong Buy7 Buy0 Hold0 Sell0 Strong Sell
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2026-03-24 | Guggenheim | maintain | Buy | Buy |
| 2026-03-24 | Piper Sandler | maintain | Overweight | Overweight |
| 2026-03-24 | D. Boral Capital | maintain | Buy | Buy |
| 2025-11-06 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2025-11-06 | D. Boral Capital | maintain | Buy | Buy |
| 2025-08-07 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2025-08-07 | D. Boral Capital | maintain | Buy | Buy |
| 2025-06-26 | Piper Sandler | maintain | Overweight | Overweight |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Fri Dec 31 | $-0.41 | $0.00 | 6 |
| Sun Dec 31 | $-0.53 | $2.5M | 7 |
| Mon Dec 31 | $-0.52 | $10.6M | 2 |
| Tue Dec 31 | $-0.36 | $64.2M | 5 |